Zobrazeno 1 - 6
of 6
pro vyhledávání: '"Ira, Fox"'
Autor:
Robert, Bolash, Michael, Creamer, Richard, Rauck, Payam, Vahedifar, Aaron, Calodney, Ira, Fox, Cuneyt, Ozaktay, Niek, Vanquathem
Publikováno v:
Pain physician. 25(1)
Novel externally powered spinal cord stimulation technology can be fully implanted when trialing the effectiveness of the therapy, since no percutaneous leads are needed, and the trial period lasted 30 days. Multiple tests of different stimulation mo
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::1d38ea15900fbeec4c880545af5f39cc
https://pubmed.ncbi.nlm.nih.gov/35051146
https://pubmed.ncbi.nlm.nih.gov/35051146
Autor:
Niek E. Vanquathem, Richard Rauck, Aaron K. Calodney, Robert Bolash, Payam Vahedifar, Sunil Panchal, Cuneyt Özaktay, Konstantin V. Slavin, Richard B. North, Ira Fox, Michael Creamer
Publikováno v:
Neuromodulation
Background "Traditional" spinal cord stimulation (SCS) trials with percutaneous electrodes externalized to a pulse generator (PG) are typically limited in duration due to risk of infection. Newer miniaturized wireless SCS technology eliminates the pe
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::c712e293cfa63f2e7e8902bcb8a7bb55
http://europepmc.org/articles/PMC7004134
http://europepmc.org/articles/PMC7004134
Autor:
Payam Vahedifar, Robert Bolash, Mezaun Yasin, Michael Creamer, Ira Fox, Niek E. Vanquathem, Aaron K. Calodney, Sunil Panchal, Richard Rauck, Cuneyt Özaktay
Publikováno v:
Pain medicine (Malden, Mass.). 20(10)
Background This study aimed to evaluate the wireless Freedom Spinal Cord Stimulator (WSCS) System for the treatment of chronic back and/or leg pain associated with failed back surgery syndrome (FBSS) refractory to standard medical treatment utilizing
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::990aed7a1ba5f64b4c07863a48e2b711
https://pubmed.ncbi.nlm.nih.gov/30908577
https://pubmed.ncbi.nlm.nih.gov/30908577
Publikováno v:
Pharmacopsychiatry. 24:127-131
In summary, the clinical results of this double-blind study clearly show that imipramine, as expected, demonstrated significant antidepressive properties in outpatients suffering from major depressive disorders. In contrast, adinazolam showed rather
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::cb8d5be80677f5eb5af8880bfc3855e7
https://doi.org/10.1055/s-2007-1014455
https://doi.org/10.1055/s-2007-1014455
Publikováno v:
Pharmacopsychiatry. 23(2)
Sixty-seven patients with panic disorder were treated with single-blind placebo for one week before being randomized to 6 weeks of double-blind treatment with either lorazepam or alprazolam. Both drugs showed significant and comparable antipanic effi
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::716da7a7a583b617e693bdfc46e9b7f6
https://pubmed.ncbi.nlm.nih.gov/2187213
https://pubmed.ncbi.nlm.nih.gov/2187213
Publikováno v:
Journal of Hepato -- Biliary -- Pancreatic Surgery; Mar2009, Vol. 16 Issue 2, p97-100, 4p